Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Zeitschrift Fur Gastroenterologie|November 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case reportSimon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, et al.JHEP Reports : Innovation in Hepatology|February 10, 2022
Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancerFelix Thol, Simon Johannes Gairing, Carolin Czauderna, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2019
Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver DiseaseEdward Gane, Fred Poordad, Neddie Zadeikis, et al.European Journal of Internal Medicine|June 4, 2018
Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCCFriedrich Foerster, Jens Mittler, Felix Darstein, et al.Journal of Hepatology|April 26, 2022
Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEALChristian Labenz, Anita Arslanow, Marc Nguyen-Tat, et al.Clinical and Translational Gastroenterology|September 10, 2022
13 C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationSimon Johannes Gairing, Robert Kuchen, Lukas Müller, et al.Journal of Cancer Research and Clinical Oncology|February 16, 2017
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin careCarl Christoph Schimanski, Frank Staib, Thomas Göhler, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2019
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantationMassimo Iavarone, Federica Invernizzi, Carolin Czauderna, et al.Plos One|September 21, 2021
How COVID-19 kick-started online learning in medical education-The DigiMed studyFabian Stoehr, Lukas Müller, Adrian Brady, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyMassimo Iavarone, Federica Invernizzi, Tommy Ivanics, et al.Pageof 9